
Insights

Subject access requests: key issues for the pharmaceuticals and life sciences sector
05 Jan 2026Subject access requests (SARs) continue to pose significant challenges for organisations in the pharmaceuticals and life sciences sector. They are often time-consuming, resource-intensive and frequently linked to wider complaints or disputes. This article shares some practical tips to help organisations manage SARs effectively.

AI and Copyright: Updates from the Data (Use and Access) Act 2025 progress statement
05 Jan 2026The DUAA progress statement provides useful insights on regulation of AI, so that businesses can proactively address risk.

US-UK tariff deal and reimbursement increase a gamechanger for UK pharma
05 Jan 2026After much uncertainty and concern, finally some incredibly positive news for the UK life sciences sector.

2026 Property industry outlook: Key reforms and market impact
04 Jan 2026As we look ahead to 2026, the property industry in England and Wales is set to face a range of legislative and regulatory changes. These reforms will have a significant impact on both the residential and commercial property sectors. Below, we outline some of the most important changes expected to influence the market in the coming year.

The Employment Rights Bill Receives Royal Assent
18 Dec 2025After months of intense debate and amendments, Labour's Employment Rights Bill has become law. This marks the most significant change in employment rights in a generation, promising sweeping reforms to strengthen workers' protections across the UK.

Government signals review of UK whistleblowing framework by 2027
18 Dec 2025The UK anti-corruption strategy 2025 confirms that reform of employment whistleblowing protections is under active consideration.





